You Lu

Sichuan University - West China Hospital

No 37, Guoxue Road

Wuhou District

Chengdu, Sichuan Province 610041

China

SCHOLARLY PAPERS

2

DOWNLOADS

83

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Nivolumab versus Docetaxel in a Predominantly Chinese Patient Population with Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 078 Randomised Phase 3 Clinical Trial

Number of pages: 31 Posted: 25 Sep 2018
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Shanghai Jiao Tong University (SJTU), Jilin Cancer Hospital, Tongji University - Department of Medical Oncology, Chinese Academy of Sciences (CAS), The Chinese University of Hong Kong (CUHK), Sun Yat-Sen University (SYSU), Guangdong Academy of Medical Sciences, Central South University - Hunan Cancer Hospital, Jiangsu Cancer Hospital - Department of Medical Oncology, Zhejiang Cancer Hospital, Leningrad Regional Clinical Hospital, Zhejiang University, Zhengzhou University - Henan Cancer Hospital, Sichuan University - West China Hospital, Central South University, Chinese Academy of Medical Sciences - Peking Union Medical College, Bristol-Myers Squibb, Bristol-Myers Squibb and Fudan University
Downloads 51 (411,556)
Citation 2

Abstract:

Loading...

nivolumab; PD-1 inhibitor; non-small-cell lung cancer; NSCLC; China; docetaxel; immunotherapy

2.

HS-10296 – A Novel Third Generation EGFR Tyrosine Kinase Inhibitor: Results of the First-in-Human Phase 1 Trial in Patients with Previously Treated EGFR Mutant Advanced Non-Small-Cell Lung Cancer

Number of pages: 160 Posted: 12 Dec 2019
National Taiwan University - Department of Oncology, University of Colorado, Aurora, Chang Gung University - Chang Gung Memorial Hospital, Zhejiang University, Nanjing University of Chinese Medicine (NJUCM) - Jiangsu Province Hospital of Traditional Chinese Medicine, Taipei Veterans General Hospital, Taichung Veterans General Hospital, Taipei Medical University, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Tongji Medical College, Chang Gung University - Chang Gung Memorial Hospital, Beverly Hills Cancer Center, National Cheng Kung University - Department of Internal Medicine, Central South University - Department of Medical Oncology, Beijing Cancer Hospital, Beijing Cancer Hospital, Central South University - Hunan Cancer Hospital, University Cancer & Blood Center, LLC, Sichuan University - West China Hospital, Zhejiang University - Department of Medical Oncology, Pacific Cancer Medical Center, Inc., University of California, San Diego (UCSD), Dartmouth College - Dartmouth-Hitchcock Medical Center, University of Miami - Sylvester Comprehensive Cancer Center, University of Texas Medical Branch-Galveston, MultiCare Institute for Research and Innovation, Baptist Healthcare Systems, Inc., China Medical University, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital and Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital
Downloads 32 (489,724)

Abstract:

Loading...

epidermal growth factor receptor; mutated; non-small-cell lung cancer; phase 1 trial; safety